Research location
Maebashi
Japan
Advertisement
Research activity in Maebashi
JapanCureCurrent currently publishes aggregate city-level research activity for this location: 41 trials and 44 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Maebashi
41 linked trials · page 1 of 1A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinNCT07662135 · 2026-07-06 · 1 site observation
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803 · 2026-06-29 · 1 site observation
RECRUITING
Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)NCT07671885 · 2026-01-28 · 1 site observation
RECRUITING
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationNCT06952803 · 2025-08-06 · 1 site observation
RECRUITING
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseNCT07082738 · 2025-06-27 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsNCT06529419 · 2024-08-30 · 2 site observations
COMPLETED
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyNCT06568042 · 2024-08-22 · 1 site observation
COMPLETED
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsNCT06120491 · 2023-11-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.NCT05763121 · 2023-01-30 · 1 site observation
TERMINATED
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)NCT04808518 · 2019-12-10 · 1 site observation
COMPLETED
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerNCT03732820 · 2018-10-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)NCT03645330 · 2018-08-15 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerNCT03085095 · 2017-04-18 · 1 site observation
COMPLETED
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)NCT02987543 · 2017-02-06 · 1 site observation
COMPLETED
Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®NCT03262012 · 2016-08-09 · 1 site observation
COMPLETED
A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesNCT02750410 · 2016-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanNCT02752828 · 2016-05-23 · 1 site observation
COMPLETED
Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsNCT02752412 · 2016-05-17 · 2 site observations
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanNCT02749890 · 2016-05-09 · 1 site observation
COMPLETED
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)NCT02497001 · 2015-08-10 · 1 site observation
COMPLETED
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaNCT02194699 · 2014-10-30 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe AsthmaNCT02054130 · 2013-12-13 · 1 site observation
COMPLETED
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate CancerNCT01756638 · 2012-06-06 · 1 site observation
COMPLETED
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received DocetaxelNCT01795703 · 2012-06-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaNCT01402986 · 2011-08-01 · 1 site observation
COMPLETED
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate CancerNCT01324583 · 2011-01-01 · 1 site observation
COMPLETED
Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate CancerNCT01193244 · 2010-10-01 · 1 site observation
COMPLETED
A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaNCT01258920 · 2010-10-01 · 1 site observation
COMPLETED
Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))NCT01163292 · 2010-03-01 · 1 site observation
COMPLETED
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsNCT00900146 · 2009-04-01 · 1 site observation
TERMINATED
A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisNCT00870467 · 2009-03-01 · 1 site observation
COMPLETED
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00876694 · 2009-03-01 · 1 site observation
COMPLETED
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00794157 · 2008-11-01 · 1 site observation
COMPLETED
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid ArthritisNCT01076959 · 2008-06-01 · 1 site observation
COMPLETED
Survey on PD Patients With Depressive SymptomsNCT00614575 · 2007-01-01 · 1 site observation
COMPLETED
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary DiseaseNCT02177318 · 2005-04-01 · 1 site observation
COMPLETED
Special Survey on Parkinson's Disease Patients Treated Long-term Use of PramipexoleNCT00615914 · 2004-02-01 · 1 site observation
COMPLETED
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-DopaNCT00613301 · 2004-02-01 · 2 site observations
COMPLETED
Special Survey on PD Patients With Renal DysfunctionNCT00613756 · 2004-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.